Clinical Trials Directory

Trials / Unknown

UnknownNCT02048423

An Open Prospective Trial of IV Ketamine in Suicidal Adolescents

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
All
Age
12 Years – 17 Years
Healthy volunteers
Not accepted

Summary

1. Investigate the safety and effectiveness of a single dose of IV Ketamine for adolescents with suicidal ideation and depression. It is hypothesize that Ketamine will be well tolerated and significantly reduce depressive symptoms and suicidal ideation. 2. Explore whether decision making as measured by the Iowa Gambling Task changes before and after Ketamine infusion. It is hypothesize that IV Ketamine infusion will significantly improve the decision making ability a measured by the Iowa Gambling Task in adolescents that are suicidal.

Detailed description

This is an open prospective study of a single, low dose (0.5 mg/kg) intravenous (IV) Ketamine in 10 adolescent subjects admitted to Nationwide Childrens Hospital following a serious suicide attempt and who meet criteria for major depression or bipolar disorder I, current episode depressed. Subjects will be recruited via the psychiatry consult service, evaluated on the floor and if eligible and consent is obtained, transferred to the PACU for IV Ketamine infusion. Following infusion and when PACU discharge criteria are met, subjects will be transferred back to their floor for medical and psychiatric monitoring until they can be transferred to an inpatient psychiatric unit for additional care. Subjects will be transferred to an inpatient psychiatric unit for continued psychiatric care as part of their routine psychiatric care via the consult team. The research team will follow-up by telephone one week and four weeks after Ketamine injection to collect additional information about the patient's overall course and response.

Conditions

Interventions

TypeNameDescription
DRUGKetamineIV Ketamine, 0.5 mg/kg X 15 mins. in PACU

Timeline

Start date
2013-06-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2014-01-29
Last updated
2014-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02048423. Inclusion in this directory is not an endorsement.